Where can Repatha (alirocumab) be injected subcutaneously?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Repatha Injection Sites

Repatha (evolocumab) should be injected subcutaneously into the abdomen, thigh, or upper arm. 1

Approved Injection Sites

According to the FDA-approved prescribing information, Repatha can be administered in three specific anatomical locations 1:

  • Abdomen (avoiding the area around the navel)
  • Thigh (anterior/lateral aspect)
  • Upper arm (posterior aspect)

Important Administration Guidelines

Site rotation is mandatory - you must rotate injection sites with each administration to prevent lipohypertrophy and ensure consistent drug absorption 1. Avoid injecting into areas that are:

  • Tender or bruised
  • Red or indurated
  • Scarred or have stretch marks

Practical Considerations

The 2022 ACC Expert Consensus specifically confirms these same three sites (thigh, abdomen, upper arm) for both alirocumab and evolocumab PCSK9 inhibitors 2. Research data supports that pharmacokinetics and pharmacodynamics are similar across all three injection sites, meaning the drug works equally well regardless of which approved site you choose 3.

For the 420 mg dose, you have two options 1:

  • Use the single-dose on-body infusor (administered over 5 minutes)
  • Give 3 consecutive injections of 140 mg within 30 minutes using different injection sites

Key Safety Note

Latex sensitivity matters - some Repatha presentations contain dry natural rubber (latex derivative) in the needle cover 1. If your patient is latex-sensitive, specifically request a latex-free presentation from the pharmacy.

The drug must be warmed to room temperature before injection: 30 minutes for prefilled syringes/autoinjectors, or 45 minutes for the on-body infusor 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.